lansoprazole has been researched along with c-peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Hao, S; Sun, J; Sun, X; Tian, X; Zhang, Z | 1 |
| Attri, SV; Dayal, D; Gupta, VK; Reddy, R; Sachdeva, N | 1 |
2 other study(ies) available for lansoprazole and c-peptide
| Article | Year |
|---|---|
Lansoprazole enhances the antidiabetic effect of sitagliptin in mice with diet-induced obesity and healthy human subjects.
Topics: Adult; Animals; Area Under Curve; Blood Glucose; C-Peptide; Diet; Drug Synergism; Drug Therapy, Combination; Glucose; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Lansoprazole; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |
Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study.
Topics: Blood Glucose; C-Peptide; Child; Cholecalciferol; Diabetes Mellitus, Type 1; Disease Progression; Humans; Insulin; Lansoprazole; Pilot Projects | 2022 |